BT Investment Management Ltd lifted its stake in Humana Inc. (NYSE:HUM) by 3.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 60,365 shares of the insurance provider’s stock after acquiring an additional 2,143 shares during the period. BT Investment Management Ltd’s holdings in Humana were worth $14,728,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. Reliance Trust Co. of Delaware boosted its holdings in shares of Humana by 0.7% in the second quarter. Reliance Trust Co. of Delaware now owns 1,123 shares of the insurance provider’s stock worth $270,000 after acquiring an additional 8 shares during the period. Creative Planning boosted its holdings in shares of Humana by 0.3% in the second quarter. Creative Planning now owns 4,874 shares of the insurance provider’s stock worth $1,173,000 after acquiring an additional 15 shares during the period. WFG Advisors LP boosted its holdings in shares of Humana by 4.5% in the second quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock worth $113,000 after acquiring an additional 20 shares during the period. Cadence Capital Management LLC boosted its holdings in shares of Humana by 0.4% in the second quarter. Cadence Capital Management LLC now owns 5,682 shares of the insurance provider’s stock worth $1,367,000 after acquiring an additional 22 shares during the period. Finally, Sit Investment Associates Inc. boosted its holdings in shares of Humana by 0.3% in the second quarter. Sit Investment Associates Inc. now owns 12,020 shares of the insurance provider’s stock worth $2,892,000 after acquiring an additional 40 shares during the period. 95.88% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: This article was published by Watch List News and is the property of of Watch List News. If you are accessing this article on another site, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://www.watchlistnews.com/bt-investment-management-ltd-has-14-73-million-stake-in-humana-inc-hum/1682553.html.

Several equities research analysts recently issued reports on HUM shares. ValuEngine lowered Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, October 10th. BidaskClub raised Humana from a “sell” rating to a “hold” rating in a research note on Wednesday, August 23rd. Jefferies Group LLC reissued a “hold” rating and set a $257.00 price objective on shares of Humana in a research note on Friday, October 13th. J P Morgan Chase & Co lowered Humana from an “overweight” rating to a “neutral” rating and set a $253.00 price objective for the company. in a research note on Monday, October 9th. Finally, Royal Bank Of Canada reissued a “hold” rating and set a $245.00 price objective on shares of Humana in a research note on Tuesday, October 10th. Thirteen analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $253.71.

Shares of Humana Inc. (HUM) traded up $0.16 on Monday, hitting $256.85. The stock had a trading volume of 39,404 shares, compared to its average volume of 962,866. Humana Inc. has a 12-month low of $165.52 and a 12-month high of $264.56. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.65 and a current ratio of 1.65. The company has a market cap of $37,096.12, a PE ratio of 22.30, a P/E/G ratio of 1.66 and a beta of 0.91.

The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.62%. The ex-dividend date is Thursday, December 28th. Humana’s dividend payout ratio is presently 13.06%.

In related news, CEO Bruce D. Broussard sold 12,000 shares of Humana stock in a transaction that occurred on Friday, August 11th. The stock was sold at an average price of $251.88, for a total value of $3,022,560.00. Following the sale, the chief executive officer now owns 80,086 shares of the company’s stock, valued at approximately $20,172,061.68. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Timothy S. Huval sold 7,803 shares of Humana stock in a transaction that occurred on Friday, September 1st. The shares were sold at an average price of $258.14, for a total value of $2,014,266.42. Following the completion of the sale, the vice president now directly owns 8,831 shares in the company, valued at approximately $2,279,634.34. The disclosure for this sale can be found here. In the last three months, insiders sold 55,595 shares of company stock worth $14,133,706. 0.80% of the stock is owned by insiders.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.